Mina Hsu

Mina Hsu currently serves as the Director of Clinical Pharmacology at Caidya since August 2024. Previously, Mina held the position of Director at LianBio from November 2020 to September 2024 and worked as a Clinical Pharmacologist at Dizal Pharma from July 2019 to November 2020. Earlier experience includes a managerial role at BioGend Therapeutics from July 2015 to July 2019, focusing on non-clinical project management, pharmacokinetics, and biocompatibility. Mina began a career in drug evaluation as a PK Reviewer at the Center of Drug Evaluation, and as a Postdoctoral Fellow at China Medical University, contributing to research on drug-resistant proteins in cancer stem cells and dietary supplement-drug interactions. Mina earned a PhD in Pharmacy from China Medical University between 2008 and 2013.